Funding In addition to its generous endowment, the Institute for Stem Cell Biology and Regenerative Medicine at Einstein is supported by external sources, including the NIH, multiple private foundations, as well as collaborations with industry. The members and laboratories of the Institute are among the top funded Investigators at the Albert Einstein College of Medicine. Currently Stem Cell Investigators are PIs on awards that total approximately $37 million, of which $27M are federal, $4.4M are from private foundations, $1.4 are from industry partners, and $3.8M are from other federal and state agencies. Einstein Benefactors The endowment for the Institute comes in large part from longtime Einstein benefactors Ruth L. and David S. Gottesman. Prior to joining the Einstein Board of Overseers in 2002, Dr. Ruth Gottesman had a distinguished 33-year academic career at the medical school. In 1968, she joined Einstein's Children's Evaluation and Rehabilitation Center (CERC) to develop a program for children with dyslexia and other learning disabilities. She went on to serve as CERC's director of psychoeducational services and later as director of the adult literacy program. In 1999, she became founding director of the Fisher Landau Center for the Treatment of Learning Disabilities, a new division of CERC that was established to provide interdisciplinary services to individuals of all ages with learning disabilities. David Gottesman is the founder and senior managing director of the First Manhattan Company, an investment advisory firm. He was chairman of the Board of Yeshiva University from 1990 to 1998.
